Chapter 256 The first chief guest reviewer!
Many people have been familiar with names such as “The Lancet” and “The New England Journal of Medicine”, but they are not very clear about what kind of organizations they are.

Simply put, both “The Lancet” and “The New England Journal of Medicine” are non-profit medical academic journals.

They receive academic papers or the latest treatment plans for a certain disease from top doctors, hospitals, and medical research institutions around the world.

At the same time, they will also invite the world’s top experts and professors to cross-review the submitted papers to ensure that every published paper is of high quality.

This is one of the important reasons why it has remained popular and become the world’s top medical journal.

of course.

If we have to say what the difference is between “The Lancet” and “The New England Journal of Medicine”, it is that “The Lancet” covers a wider range of content, pays special attention to global public health issues, and focuses on comprehensive and in-depth discussions of new medical concepts and new treatment technologies.

To put it more bluntly, The Lancet prefers to convey more key information in its titles, which makes them more readable and disseminable.

The New England Journal of Medicine is the oldest medical journal and its content focuses more on professional fields such as internal medicine, immunology and cardiology.

At the same time, most of the articles it publishes are high-quality clinical research and review articles, emphasizing the rigor and scientific nature of the research, and even most of the content has very good guiding significance for clinical practice.

For this reason, the New England Journal of Medicine is more professional and scientific, and its audience is mostly medical professionals and researchers.

Oh, there is one more difference.

The Lancet is a medical journal founded in the UK. Although it has a wide influence around the world, it is mainly concentrated in Europe and Asia, where it receives particular attention.

As the name suggests, the New England Journal of Medicine originated in the United States, so its influence and authority in the medical academic circle in North America is slightly higher than that of The Lancet.

But anyway,
Both “The Lancet” and “The New England Journal of Medicine” are undoubtedly the world’s first and second top medical journals. Being able to publish a professional academic paper in them can be said to be the lifelong wish of countless experts, professors in the medical field and practitioners in major scientific research institutions.

Correct!
A lifelong wish!
Don’t think it’s an exaggeration.

You know, being able to publish a professional academic paper in “The Lancet” or “The New England Journal of Medicine” means that one’s academic level has reached the top ranks in the world in this field. This is a recognition of academic status and a symbol of identity!

In China’s medical community, if you can publish an academic paper in “The Lancet”, you can be said to have directly become an absolute leader in the field. No matter which hospital or research institution you go to, you will be looked up to by others.

Once, a university in Shanghai directly awarded a reward of 600,000 yuan to an author who published a paper in The Lancet, and also politely invited him to be a visiting professor.

In 2016, after an academic paper from Shancheng Medical University was accepted by The Lancet, it even published a special article to celebrate this “historic” moment.

It can be said that all signs show how difficult it is to be selected for “The Lancet”.

of course.

The reason why “The Lancet” and “The New England Journal of Medicine” have such a great influence is that modern medicine originated in the West.

No, to be precise, the center of development of modern medicine has always been in the West.

Therefore, in the past hundred years, all parts of the world have been learning advanced Western clinical knowledge and advanced treatment concepts, which has also led to the prosperity and authority of “The Lancet” and “The New England Journal of Medicine”.

but……

Things seem to be a little different now, especially in the field of hematology.

Zhang Yang’s eyes fell on the exquisite invitation letter on the desk again. The signature on it was – “China Medical Frontier Journal”.

After a moment, he raised his head and looked at an old acquaintance whom he had not seen for a long time – Dean Zhou of the Third People’s Court of Chengdu.

“President Zhou… No, I should call you Director Zhou now!”

“You’ve really become a very busy person. I think I haven’t seen you for half a year!”

Standing in front of Zhang Yang was Dean Zhou, whom he hadn’t seen for a long time.

No, it’s Director Zhou.

Last year, the hospital held an election for a new term. With the outstanding achievements he had made in recent years with the support of Qingshan Pharmaceutical, Director Zhou successfully broke through the siege and was promoted to the position of deputy director of the Provincial Health Commission as he wished.

Since I had just arrived, I was naturally busy with work, so I had much less time to contact Zhang Yang.

“Mr. Zhang, it’s too formal for you to call me that. You should just call me Lao Zhou or Dean Zhou like before.”

“Besides, what kind of director is he? He’s just a deputy director, a deputy director!”

“Ha ha!”

Zhang Yang couldn’t help laughing and said jokingly:

“Director Zhou, you are now the deputy director, but I know that with your ability, it is only a matter of time before you become the full-time director!”

As he spoke, he tapped the invitation letter on the desk with his fingers and said:
“Well, Dean Zhou, I really didn’t expect you to take the lead in establishing a ‘Chinese Medical Frontier Journal’ without saying anything. It really surprised me. How did you suddenly think of doing this?”

“Moreover, you asked Director Hu to publish the world’s first clinical treatment paper on ‘Ibeumab’ in the ‘Chinese Journal of Medical Frontiers’. You are quite ambitious!”

“besides!”

Zhang Yang paused, looked at the invitation letter again, and finally looked up at Dean Zhou.

“Also, are you sure you want to invite me to be a special guest reviewer for the ‘China Medical Frontier Journal’?”

Dean Zhou nodded heavily without any hesitation.

“Yes, we sincerely invite you to become a guest reviewer for the ‘China Medical Frontier Journal’.”

After saying this, he couldn’t help but look at the invitation letter and suddenly laughed:

“As for why this ‘Huaxia Medical Frontier Journal’ was suddenly established…”

“In fact, I won’t hide it from you. This year, the leaders mentioned that we should find a way to increase the international influence of our Chinese medical community, so…”

“It just so happens that our Qingshan Pharmaceutical has developed a miracle drug for leukemia called ‘Ivacuzumab’, plus the previous ‘ITG human myelopoietin’, so we simply set up a new, influential medical journal focusing on leukemia!”

“what?!”

Hearing this, Zhang Yang was stunned and burst into laughter.

I have to say, this is Dean Zhou, he really wants to make progress.

“It’s just…”

Dean Zhou didn’t care about Zhang Yang’s bitter smile and continued:

“I just really want to thank Lao Hu (Director Hu) for giving me great support and giving me enough face this time.”

“It is said that the editor-in-chief of The Lancet sent an email to Lao Hu to ask him to contribute to the article, but in the end Lao Hu still published the first-hand clinical treatment plan of ‘ibumaxin’ in our newly established ‘China Medical Frontier Journal’.”

“As for your last question, it’s not just my opinion that I want to invite you to be a guest reviewer for our ‘China Medical Frontier Journal’!”

“The establishment of our ‘China Medical Frontiers Journal’ has received strong support from professors from famous hospitals such as West China Hospital, Chengdu Third People’s Hospital, Shanghai Ruijin Hospital, and Beijing Union Hospital. It was these professors who strongly requested at the first journal conference that I must invite you to join as the chief guest reviewer of the journal!” “Otherwise, they are worried about the prospects of the ‘China Medical Frontiers Journal’!”

Thinking of this, Dean Zhou couldn’t help but reveal a bitter smile with emotion on his face. He glanced at Zhang Yang and said:

“You don’t know that when those top professors mentioned you, their eyes flickered with strangeness. Many of them respected you very much and praised you highly!”

“It even seems to me that many professors really regard you as the backbone of the journal!”

“If you don’t join, no one will have confidence; if you join, everyone will feel stable.”

Zhang Yang was stunned and subconsciously touched the tip of his nose.

“Am I that powerful?”

“Of course!”

Dean Zhou flattered him without hesitation.

“Zhang Yang, you also know that both The Lancet and the New England Journal of Medicine have great influence around the world. They have become the “holy land” in the hearts of countless medical professors and researchers around the world. Countless people dream of publishing a paper in them.”

“But what about our country? There are no medical journals that are worth mentioning, let alone any influence in the world.”

“Now it is you and Qingshan Pharmaceutical that have absolute influence in the field of blood diseases!”

“In my words, you are now the undisputed leader of our Chinese medical community, the real leader!”

Zhang Yang felt a little embarrassed after hearing this. He waved his hands, but he still couldn’t help feeling a little happy in his heart.

“Of course, we can’t say that the ‘China Medical Frontiers Journal’ will catch up with the UK and the US as soon as it is established, and will directly replace the ‘Lancet’ and the ‘New England Journal’. This is unrealistic!”

“But we must at least find a way to expand the global influence of the ‘China Medical Frontier Journal’, so… this matter requires a world-class celebrity to take charge!”

“You are undoubtedly the best candidate in everyone’s mind!”

It has to be said that Dean Zhou’s two flatteries were really satisfying, and Zhang Yang felt very comfortable inside as well.

Moreover, deep down, Zhang Yang really hopes that a more influential medical journal will emerge in China. This will not only enhance the influence of domestic medicine, but also indirectly enhance the domestic medical capabilities to a higher level.

After all, whether it is “The Lancet” or “The New England Journal”, the real top papers are all written in English, and there are actually not many doctors in China who can read them fluently.

Once the quality of domestic medical journals improves significantly, most ordinary doctors in the country, especially those in tertiary hospitals in third- and fourth-tier cities, will be able to more easily obtain better, more authoritative, and more advanced clinical paper materials.

The cost of learning is greatly reduced.

“Okay, since you’ve said this, Old Zhou, I can’t refuse anymore!”

“I am willing to accept your invitation to become the first special guest reviewer of the ‘Hua Xia Medical Frontier Journal’.”

“It’s just that… my level is limited. I have made some achievements in the field of drug research and development. I don’t really know much about other clinical medicine.”

Dean Zhou immediately showed a bright smile on his face. He certainly knew what Zhang Yang’s strengths were.

Besides, he had never thought of asking Zhang Yang to review a lot of manuscripts. As the boss of Qingshan Pharmaceutical, Zhang Yang was very busy with all kinds of affairs every day. How could he have time to review manuscripts? !
As long as Zhang Yang agrees to join, with Zhang Yang’s influence, even if he is just a mascot and does nothing, he is still a leader!

Spiritual leader!

“Zhang Yang, what you said is too polite. Your level is definitely top-notch in the world!”

“Of course, don’t worry. The clinical medicine papers will be cross-examined by several experts from Union Hospital. You will mainly be responsible for the papers on drug development.”

“That’s good!”

Zhang Yang nodded, then solemnly put the invitation letter on the desk into the drawer.

Seeing this, Dean Zhou was completely relieved.

After a moment, he returned to the coffee table, picked up the teacup and took two big sips, then walked back to Zhang Yang’s desk again, with a cunning look in his eyes.

“Zhang Yang, we have now reached an agreement on the ‘China Medical Frontiers Journal’ matter.”

“You have become the first special guest reviewer of the ‘China Medical Frontier Journal’. Can you tell me if you have made any breakthroughs in new drugs recently?”

“For example, are there any drugs for cancer or rare diseases? I can also use this opportunity to promote the ‘China Medical Frontier Journal’.”

Zhang Yang was stunned and couldn’t help but smile bitterly:
“Dean Zhou, I said that the title of ‘first special guest reviewer’ is not so easy to accept, and your flattery is not so easy to accept.”

“So you were waiting for me here. You’ve almost plucked all my wool out of my body.”

“But…we haven’t had any breakthrough drugs recently!”

“Of course, if we have to say there is a project that is more urgent to advance, there is indeed one. As you know, the Saudi royal family previously provided us with a considerable amount of research funds to develop a drug that can completely cure hemophilia, but…”

“There won’t be much progress in a short period of time!”

Dean Zhou certainly knew about the agreement between Qingshan Pharmaceutical and the Saudi prince on hemophilia. At the same time, he also knew that this matter had just happened not long ago, and no matter how fast Qingshan Pharmaceutical was, it would be impossible to achieve results in such a short time.

However, he was not “anxious to wait for the rice to cook”, and laughed:

“ok, I get it.”

“But I’m not in a hurry. After all, Ibelumab is only in Phase II clinical trials, and Lao Hu has just published a paper!”

“Also, when I came here just now, I received a call from Lao Hu, saying that Dr. Richard from the Royal London Hospital in the UK hopes to come to Chengdu to learn about the clinical treatment plan of ‘Ibeumab’ and is also willing to submit an article to our ‘Frontier Medical Journal’!”

“Dr. Richard is one of the top hematologists in Europe and even the world. With such a doctor’s contribution, the influence of our Frontier Medical Journal will surely increase greatly!”

“Anyway, I’m not in a hurry. There’s still enough wool from ‘Ibeumab’ for us at ‘Frontiers’ to make some money!”

Zhang Yang was speechless for a moment… This seemed to be what Dean Zhou said.

but.

After a while, after Dean Zhou left contentedly, Zhang Yang started thinking about this problem again.

“Next, where should Qingshan Pharmaceutical focus its research and development?”

“T14 pneumonia virus?”

“hemophilia?”

“Or…something else?!”

(End of this chapter)